[1] |
HE Yi-jun, CAO Xue-fang, GAO Lei.
Interpretation of the Procedure of tuberculin skin test-interferon-gamma release assay two-step testing
[J]. Chinese Journal of Antituberculosis, 2022, 44(5): 438-441.
|
[2] |
JIN Xiao-wei, LI Ya-ru, DUAN Hai-xia, WEI Xiao-hui, PEI Yi-yi, LI Ying, JIN Hong-jian.
Study on active screening of pulmonary tuberculosis among key population in key areas of Xinmi, He’nan
[J]. Chinese Journal of Antituberculosis, 2022, 44(5): 467-472.
|
[3] |
SUN Qing, LIAO Xin-lei, WANG Chen-qian, JIANG Guang-lu, DONG Ling-ling, WANG Fen, ZHAO Li-ping, HUANG Hai-rong, WANG Gui-rong.
Characterization of rifampin resistance determining region mutations in tuberculosis patients with GeneXpert MTB/RIF positive RNA polymerase β subunit gene mutation
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 349-353.
|
[4] |
TIAN Li, ZHOU Wei, HUANG Xing, WU Xian-wei, ZHANG Hui-yong, LU Zhen-hui, ZHANG Shao-yan.
Analysis of gene mutation characteristics of isoniazid-resistant Mycobacterium tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 354-361.
|
[5] |
WANG Yan, FANG Hong-xia, ZHENG Kai-qiao, TAN Xiao-ping, HUANG Dong-sheng, SU Lian-hui, LIU Chang-wei.
Analysis of the effect of strengthening tuberculosis etiological examination on hospitalized patients from respiratory department of general hospital in Longhua of Shenzhen between 2018 and 2020
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 368-374.
|
[6] |
MA Yan, LU Wei, GAO Lei, CHU Nai-hui, ZHOU Lin, CHENG Shi-ming.
To end tuberculosis epidemic needs strengthen the management of screening and preventive treatment of latent tuberculosis infection in high-risk groups
[J]. Chinese Journal of Antituberculosis, 2022, 44(3): 209-214.
|
[7] |
LI Dong-shuo, WANG Bin, LU Yu, XU Jian.
Study of expression and function of Mycobacterium tuberculosis membrane protein MmpL5-MmpS5
[J]. Chinese Journal of Antituberculosis, 2022, 44(3): 227-233.
|
[8] |
FAN Ru, LI Xiao-fei.
Research progress of molecular biology detection technology for tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(3): 294-298.
|
[9] |
SUN Zhao-gang.
Attention should be paid to the research and development of Mycobacterium tuberculosis antigen detection technology
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 120-124.
|
[10] |
LEI Jing, WU Xia, TAN Xiao-wen, LI Ai-fang, CUI Xiao-li, KANG Lei, PANG Jian-jian, REN Fei, WU Shou-zhen, YANG Han.
Diagnostic value of GeneXpert MTB/RIF Ultra in testing surgical tissue specimens for diagnosing tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 141-146.
|
[11] |
JIN Long, TIAN Qi, ZHANG Bao-qing, XING Hai-dong, GAO Ming-xia, ZHANG Xiu-ying, WANG Li-hua, ZHANG Xiao-lei.
Research of effectiveness of fluorescence PCR melting curve assay in detecting drug resistance of levofloxacin and moxifloxacin in patients with multidrug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 159-163.
|
[12] |
WANG Shao-hua, ZHAO Guo-lian, WANG Pei, TAN Xiao-wen, CUI Xiao-li, KANG Lei, DANG Li-yun.
Analysis of inconsistency between genotypic and phenotypic results of Mycobacterium tuberculosis rifampicin susceptibility test
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 169-173.
|
[13] |
ZHANG Can-you, CHEN Hui, FA Li-feng, ZHANG Hui, CHENG Jun.
Evaluation of the effects of tuberculosis infection control training courses in China, 2016-2019
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 174-180.
|
[14] |
ZHOU Ting-ting, ZHENG Xiao-man, OUYANG Jing, LU Yan-qiu, CHEN Yao-kai.
Research progress on genes and mechanism of Mycobacterium tuberculosis resistance to pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 102-105.
|
[15] |
Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College , Chinese Center for Disease Control and Prevention , Union Medical Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences .
Expert consensus on the estimation of the national burden on latent tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 4-8.
|